665 related articles for article (PubMed ID: 34044572)
1. Study on the application effect of bisoprolol combined with sacubitril valsartan sodium tablets in the cardiac rehabilitation of patients with acute myocardial infarction combined with left heart failure after percutaneous coronary intervention (PCI).
Chen C; Wu X; Li Y; Peng Y
Ann Palliat Med; 2021 May; 10(5):5455-5461. PubMed ID: 34044572
[TBL] [Abstract][Full Text] [Related]
2. Improved heart function and cardiac remodelling following sacubitril/valsartan in acute coronary syndrome with HF.
Liu H; Su Y; Shen J; Jiao Y; Li Y; Liu B; Hou X; Jin Q; Chen Y; Sun Z; Xi Q; Feng B; Fu Z
ESC Heart Fail; 2024 Apr; 11(2):937-949. PubMed ID: 38224955
[TBL] [Abstract][Full Text] [Related]
3. [Effect of sacubitril/valsartan on cardiac function in heart failure rabbits with preserved ejection fraction].
Gao SY; Yao DH; Li JF; Xie QM; Jiang SC
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):887-893. PubMed ID: 31744278
[No Abstract] [Full Text] [Related]
4. The effect of Sacubitril/Valsartan on cardiac function and cardiac remodeling in patients with heart failure with reduced ejection fraction.
Chen F; Tian G; Bai X; Li J; Yuan Z
Ann Palliat Med; 2021 Aug; 10(8):8684-8691. PubMed ID: 34488357
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects and safety of early use of sacubitril/valsartan after acute myocardial infarction: a systematic review and meta-analysis.
Zhang L; Yan K; Zhao H; Shou Y; Chen T; Chen J
Ann Palliat Med; 2022 Mar; 11(3):1017-1027. PubMed ID: 35365031
[TBL] [Abstract][Full Text] [Related]
6. The Value of Sacubitril/Valsartan in Acute Anterior Wall ST-Segment Elevation Myocardial Infarction before Emergency Percutaneous Coronary Intervention.
Lin G; Chen W; Wu M; Dai C; Xu K
Cardiology; 2022; 147(5-6):479-485. PubMed ID: 36198259
[TBL] [Abstract][Full Text] [Related]
7. A study of the efficacy of sacubitril/valsartan plus dapagliflozin combination treatment in pulmonary arterial hypertension due to left heart disease.
Ge T; Yang Y; Zhao Y
Perfusion; 2023 Nov; 38(8):1697-1704. PubMed ID: 36173344
[TBL] [Abstract][Full Text] [Related]
8. [Sacubitril/valsartan attenuates left ventricular remodeling and improve cardiac function by upregulating apelin/APJ pathway in rats with heart failure].
Liu HZ; Gao CY; Yuan F; Xu Y; Tian H; Wang SQ; Zhang PF; Shi YN; Wei JJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Jul; 50(7):690-697. PubMed ID: 35856226
[No Abstract] [Full Text] [Related]
9. Efficacy and safety of sacubitril valsartan in treating heart failure with midrange ejection fraction after acute myocardial infarction in diabetic patients.
Ye F; Li H; Chen X; Wang Y; Lin W; Chen H; Huang S; Han S; Guan F; Huang Z
Medicine (Baltimore); 2022 Feb; 101(5):e28729. PubMed ID: 35119021
[TBL] [Abstract][Full Text] [Related]
10. The Difference between Sacubitril Valsartan and Valsartan on Vascular Endothelial Function, APN, MMP-9, and BNP Levels in Patients with Hypertension and Chronic Heart Failure.
Du H; Li X; Zhao W; Jiang N
J Healthc Eng; 2022; 2022():9494981. PubMed ID: 35222898
[TBL] [Abstract][Full Text] [Related]
11. Clinical Effect of Qili Qiangxin Capsule Combined with Sacubitril-Valsartan in Patients with Chronic Heart Failure.
Yao J; Liu D
J Healthc Eng; 2022; 2022():8598806. PubMed ID: 35368935
[TBL] [Abstract][Full Text] [Related]
12. Effect of sacubitril valsartan on cardiac function and endothelial function in patients with chronic heart failure with reduced ejection fraction.
Li BH; Fang KF; Lin PH; Zhang YH; Huang YX; Jie H
Clin Hemorheol Microcirc; 2021; 77(4):425-433. PubMed ID: 33386797
[TBL] [Abstract][Full Text] [Related]
13. Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients With Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial Infarction.
Docherty KF; Campbell RT; Brooksbank KJM; Dreisbach JG; Forsyth P; Godeseth RL; Hopkins T; Jackson AM; Lee MMY; McConnachie A; Roditi G; Squire IB; Stanley B; Welsh P; Jhund PS; Petrie MC; McMurray JJV
Circulation; 2021 Jul; 144(3):199-209. PubMed ID: 33983794
[TBL] [Abstract][Full Text] [Related]
14. Effect of sacubitril-valsartan on left ventricular remodeling in patients with acute myocardial infarction after primary percutaneous coronary intervention: a systematic review and meta-analysis.
Liu Y; Sun Y; Dai W
Front Pharmacol; 2024; 15():1366035. PubMed ID: 38863978
[TBL] [Abstract][Full Text] [Related]
15. Reverse Cardiac Remodeling Following Initiation of Sacubitril/Valsartan in Patients With Heart Failure With and Without Diabetes.
Khan MS; Felker GM; Piña IL; Camacho A; Bapat D; Ibrahim NE; Maisel AS; Prescott MF; Ward JH; Solomon SD; Januzzi JL; Butler J
JACC Heart Fail; 2021 Feb; 9(2):137-145. PubMed ID: 33309581
[TBL] [Abstract][Full Text] [Related]
16. Effects and Safety of Sacubitril/Valsartan for Patients with Myocardial Infarction: A Systematic Review and Meta-Analysis.
Liu L; Ding X; Han Y; Lv J
J Healthc Eng; 2022; 2022():7840852. PubMed ID: 35035857
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of enhanced external counter pulsation plus sacubitril/valsartan in the treatment of patients with chronic heart failure and the effect on ankle-arm index and cardiac function.
Huang XL; Wang XJ; Chen BT; Chen YN
Eur Rev Med Pharmacol Sci; 2023 Apr; 27(8):3300-3312. PubMed ID: 37140280
[TBL] [Abstract][Full Text] [Related]
18. The initial timing and dosage pattern of sacubitril/valsartan in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Gu J; Wang Y; Wang CQ; Zhang JF
Eur J Intern Med; 2023 Jun; 112():62-69. PubMed ID: 36990878
[TBL] [Abstract][Full Text] [Related]
19. Effects of Dapagliflozin in Combination with Metoprolol Sustained-Release Tablets on Prognosis and Cardiac Function in Patients with Acute Myocardial Infarction after PCI.
Zhang H; Liu Z
Comput Math Methods Med; 2022; 2022():5734876. PubMed ID: 35966250
[TBL] [Abstract][Full Text] [Related]
20. Effect of Emergency Percutaneous Coronary Intervention Combined with Sacubitril and Valsartan on the Cardiac Prognosis in Patients with Acute Myocardial Infarction.
Fan H; Wang Y; Wang X; Dong X; Shao X; Yang F
Int J Gen Med; 2023; 16():499-505. PubMed ID: 36785558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
